[脱发与帕罗西汀使用:一个案例报告]。

IF 1.3 4区 医学 Q4 PSYCHIATRY
Faruk Kurhan, Gülsüm Zuhal Kamış
{"title":"[脱发与帕罗西汀使用:一个案例报告]。","authors":"Faruk Kurhan, Gülsüm Zuhal Kamış","doi":"10.5080/u24955","DOIUrl":null,"url":null,"abstract":"Diverse dermatological side effects in relation to using psychotropic agents, include the serious outcomes as hypersensitivity and StevensJohnson syndrome as well as milder forms as ecchymosis and hair loss. Whereas hair loss is frequently associated with mood stabilizers, rarely ,it is also attributed to antidepressants. Selective serotonin reuptake inhibitors (SSRIs) which are the first choice treatment for depression, anxiety disorders and obsessive-compulsive spectrum disorders, are the most commonly used antidepressant drugs. Psychiatric comorbidities have been known in many dermatological diseases and their treatment have positive effects on the course and outcome as well as on the adaptation process to the disease. Due to their favorable side effect profile, for comorbid cases SSRIs are frequently used. Here we present a case of hair loss during paroxetine in a 24-year-old male with social anxiety disorder. In this case the hair loss improved after discontinuing and recurred after resuming paroxetine. After replacing paroxetine with sertraline, another SSRI, alopecia did not recur.","PeriodicalId":47266,"journal":{"name":"Turk Psikiyatri Dergisi","volume":"32 1","pages":"61-64"},"PeriodicalIF":1.3000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"[Hair Loss Associated with Paroxetine Use: A Case Report].\",\"authors\":\"Faruk Kurhan, Gülsüm Zuhal Kamış\",\"doi\":\"10.5080/u24955\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Diverse dermatological side effects in relation to using psychotropic agents, include the serious outcomes as hypersensitivity and StevensJohnson syndrome as well as milder forms as ecchymosis and hair loss. Whereas hair loss is frequently associated with mood stabilizers, rarely ,it is also attributed to antidepressants. Selective serotonin reuptake inhibitors (SSRIs) which are the first choice treatment for depression, anxiety disorders and obsessive-compulsive spectrum disorders, are the most commonly used antidepressant drugs. Psychiatric comorbidities have been known in many dermatological diseases and their treatment have positive effects on the course and outcome as well as on the adaptation process to the disease. Due to their favorable side effect profile, for comorbid cases SSRIs are frequently used. Here we present a case of hair loss during paroxetine in a 24-year-old male with social anxiety disorder. In this case the hair loss improved after discontinuing and recurred after resuming paroxetine. After replacing paroxetine with sertraline, another SSRI, alopecia did not recur.\",\"PeriodicalId\":47266,\"journal\":{\"name\":\"Turk Psikiyatri Dergisi\",\"volume\":\"32 1\",\"pages\":\"61-64\"},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Turk Psikiyatri Dergisi\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.5080/u24955\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Turk Psikiyatri Dergisi","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5080/u24955","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 1

摘要

与使用精神药物有关的各种皮肤病副作用,包括严重的结果,如过敏和史蒂文斯·约翰逊综合征,以及轻度的形式,如瘀斑和脱发。虽然脱发通常与情绪稳定剂有关,但很少与抗抑郁药有关。选择性血清素再摄取抑制剂(SSRIs)是治疗抑郁症、焦虑症和强迫症的首选药物,也是最常用的抗抑郁药物。精神合并症在许多皮肤病中都是已知的,它们的治疗对病程和结局以及对疾病的适应过程都有积极的影响。由于其良好的副作用,对于合并症的病例,经常使用ssri类药物。在这里,我们提出一个病例脱发帕罗西汀期间在一个24岁的男性社交焦虑症。在这种情况下,脱发在停药后得到改善,在恢复帕罗西汀后复发。在用舍曲林(另一种SSRI)代替帕罗西汀后,脱发没有复发。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
[Hair Loss Associated with Paroxetine Use: A Case Report].
Diverse dermatological side effects in relation to using psychotropic agents, include the serious outcomes as hypersensitivity and StevensJohnson syndrome as well as milder forms as ecchymosis and hair loss. Whereas hair loss is frequently associated with mood stabilizers, rarely ,it is also attributed to antidepressants. Selective serotonin reuptake inhibitors (SSRIs) which are the first choice treatment for depression, anxiety disorders and obsessive-compulsive spectrum disorders, are the most commonly used antidepressant drugs. Psychiatric comorbidities have been known in many dermatological diseases and their treatment have positive effects on the course and outcome as well as on the adaptation process to the disease. Due to their favorable side effect profile, for comorbid cases SSRIs are frequently used. Here we present a case of hair loss during paroxetine in a 24-year-old male with social anxiety disorder. In this case the hair loss improved after discontinuing and recurred after resuming paroxetine. After replacing paroxetine with sertraline, another SSRI, alopecia did not recur.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.30
自引率
11.10%
发文量
15
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信